Quality of Life Evaluation in Saudi Arabian Pediatric Patients with Primary Immunodeficiency Diseases Receiving 20% Subcutaneous IgG Infusions at Home

被引：0
|
作者：
Bandar Al-Saud
Nora AlRumayyan
Areej Alfattani
Sawsan Abu Awwad
Dema Al Saud
Reem Mohammed
Sultan Albuhairi
Sahar Elshorbagi
Sakra S. Balhareth
Hasan Al-Dhekri
Rand Arnaout
Edward B. De Vol
Hamoud Al-Mousa
机构：
[1] King Faisal Specialist Hospital & Research Center,Section of Pediatric Allergy/Immunology, Department of Pediatrics
[2] Alfaisal University,College of Medicine
[3] King Faisal Specialist Hospital & Research Centre,Biostatistics, Epidemiology and Scientific Computing Department
[4] King Faisal Specialist Hospital & Research Center,Nursing affairs
[5] King Faisal Specialist Hospital & Research Center,Pharmaceutical Care Division
来源：
Journal of Clinical Immunology | 2023年 / 43卷
关键词：
Immunoglobulin replacement therapy; intravenous immunoglobulin; primary antibody deficiency; hypogammaglobinemia; severe combined immunodeficiency;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1360 / 1366
页数：6
相关论文
共 50 条
  • [41] An evaluation of the budget impact of a new 20% subcutaneous immunoglobulin (Ig20Gly) for the management of primary immunodeficiency diseases in Switzerland
    Pollock, Richard F.
    Meckley, Lisa M.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2018, 10 : 223 - 229
  • [42] Formulation Preferences, Satisfaction, and Quality of Life in Patients Receiving Intravenous Biologics for Inflammatory Bowel Disease: A Saudi Arabian Study
    Meeralam, Yaser
    Alotaibi, Salem
    Alsaedi, Mona
    Alzanbagi, Adnan
    Khan, Mohammed
    Sulaimani, Mohammed
    Samanudi, Abdullah
    Osman, Mohamed
    Alhalwagy, Hesham
    Tashkhandi, Abdulaziz
    Shariff, Mohammed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S808 - S808
  • [43] Treatment preference on the new Subcutaneous Immunoglobulin 20% (SCIG 20%) treatment in patients with Primary Immunodeficiency Diseases (PID) in Europe (EU)
    Gladiator, A.
    Meckley, L.
    Berner, T.
    Engl, W.
    Ito, D.
    Yel, L.
    SWISS MEDICAL WEEKLY, 2017, 147 : 57S - 57S
  • [44] TREATMENT PREFERENCE ON THE NEW SUBCUTANEOUS IMMUNOGLOBULIN 20% (SCIG 20%) TREATMENT IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PIDD) IN EUROPE (EU)
    Meckley, Lisa
    Berner, Todd
    Engl, Werner
    Ito, Diane
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 (02) : 202 - 203
  • [45] A pilot study of quality of life, mood, sleepiness and fatigue in patients with primary immunodeficiency receiving IVIG
    Kanani, A. S.
    Schellenberg, R. R.
    Stark, D. F.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S251 - S251
  • [46] Health-related quality of life in patients with primary immunodeficiencies in North America receiving home-based subcutaneous immunologlobulin replacement therapy
    Nicolay, U
    Kiessling, P
    Gardulf, A
    Ochs, HD
    CLINICAL IMMUNOLOGY, 2005, 115 : S247 - S247
  • [47] The HILO Study: High Volumes and Flow Rates of Subcutaneous IgPro20 Pump-assisted Infusions in Patients with Primary Immunodeficiency
    Anderson, John
    Bonagura, Vincent
    Cowan, Juthaporn
    Hu, Chengping
    Mustafa, Shahzad
    Patel, Niraj
    Routes, John
    Sriaroon, Panida
    Vinh, Donald
    Hofmann, Jutta
    Rojavin, Mikhail
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB216 - AB216
  • [48] Analysis of Safety and Tolerability Data in Pediatric Patients with Primary Immunodeficiency Diseases from Two Phase 2/3 Studies of Human Immune Globulin Subcutaneous, 20%
    Paris, Kenneth
    Haddad, Elie
    Hussain, Iftikhar
    Brodszki, Nicholas
    Darter, Amy Liebl
    Engl, Werner
    Mccoy, Barbara
    Yel, Leman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB217 - AB217
  • [49] Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America
    Daniel Suez
    Mark Stein
    Sudhir Gupta
    Iftikhar Hussain
    Isaac Melamed
    Kenneth Paris
    Amy Darter
    Christelle Bourgeois
    Sandor Fritsch
    Heinz Leibl
    Barbara McCoy
    David Gelmont
    Leman Yel
    Journal of Clinical Immunology, 2016, 36 : 700 - 712
  • [50] Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America
    Suez, Daniel
    Stein, Mark
    Gupta, Sudhir
    Hussain, Iftikhar
    Melamed, Isaac
    Paris, Kenneth
    Darter, Amy
    Bourgeois, Christelle
    Fritsch, Sandor
    Leibl, Heinz
    McCoy, Barbara
    Gelmont, David
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (07) : 700 - 712
12345